Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-09-05

Clinical Trial Update: Humoral Determinants of Immunity to Pneumococcal Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying humoral determinants of immunity to pneumococcal infection, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Pneumonia, Pneumococcal Infections | Phase 4 | Status: COMPLETED